"L'Hôpital Privé du Confluent (nouveau nom des Nouvelles Cliniques Nantaises et du Centre Catherine de Sienne depuis 2016) est un établissement de santé pluridisciplinaire situé à Nantes, en Pays de la Loire. Il fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée. L'établissement propose des activités de consultation et d'hospitalisation en court séjour de médecine, chirurgie, cancérologie et cardiologie. Cet établissement dispose d'un service d'urgences 24h/24. L'Hôpital Privé du Confluent rassemble 200 praticiens exerçant une cinquantaine de spécialités, et plus de 1 100 salariés. Il est régulièrement classé parmi les meilleurs établissements privés de France."

During the past decade, Hopital Prive du Confluent conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Prive du Confluent" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Prive du Confluent" are "BRCA 1 Gene Mutation" (2 trials), "BRCA 2 Gene Mutation" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hopital Prive du Confluent" in a lesser frequency.

Most popular intervention types in "Hopital Prive du Confluent" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "talazoparib" (2 trials) and "Physician's-Choice" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Prive du Confluent" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Prive du Confluent". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Prive du Confluent, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Prive du Confluent, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".